These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 23380522)
1. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats. Mørk A; Montezinho LP; Miller S; Trippodi-Murphy C; Plath N; Li Y; Gulinello M; Sanchez C Pharmacol Biochem Behav; 2013 Apr; 105():41-50. PubMed ID: 23380522 [TBL] [Abstract][Full Text] [Related]
2. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory. Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057 [TBL] [Abstract][Full Text] [Related]
3. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study. Pehrson AL; Cremers T; Bétry C; van der Hart MG; Jørgensen L; Madsen M; Haddjeri N; Ebert B; Sanchez C Eur Neuropsychopharmacol; 2013 Feb; 23(2):133-45. PubMed ID: 22612991 [TBL] [Abstract][Full Text] [Related]
4. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism. du Jardin KG; Jensen JB; Sanchez C; Pehrson AL Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. Mørk A; Pehrson A; Brennum LT; Nielsen SM; Zhong H; Lassen AB; Miller S; Westrich L; Boyle NJ; Sánchez C; Fischer CW; Liebenberg N; Wegener G; Bundgaard C; Hogg S; Bang-Andersen B; Stensbøl TB J Pharmacol Exp Ther; 2012 Mar; 340(3):666-75. PubMed ID: 22171087 [TBL] [Abstract][Full Text] [Related]
7. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism. Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134 [TBL] [Abstract][Full Text] [Related]
8. Involvement of 5-HT₇ receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents. Westrich L; Haddjeri N; Dkhissi-Benyahya O; Sánchez C Neuropharmacology; 2015 Feb; 89():382-90. PubMed ID: 25446573 [TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission. Riga MS; Sánchez C; Celada P; Artigas F Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166 [TBL] [Abstract][Full Text] [Related]
10. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Sanchez C; Asin KE; Artigas F Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186 [TBL] [Abstract][Full Text] [Related]
11. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374 [TBL] [Abstract][Full Text] [Related]
12. Chronic Vortioxetine Treatment Reduces Exaggerated Expression of Conditioned Fear Memory and Restores Active Coping Behavior in Chronically Stressed Rats. Hatherall L; Sánchez C; Morilak DA Int J Neuropsychopharmacol; 2017 Apr; 20(4):316-323. PubMed ID: 27927740 [TBL] [Abstract][Full Text] [Related]
13. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats. Leiser SC; Pehrson AL; Robichaud PJ; Sanchez C Br J Pharmacol; 2014 Sep; 171(18):4255-72. PubMed ID: 24846338 [TBL] [Abstract][Full Text] [Related]
14. Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures. Waller JA; Chen F; Sánchez C Neuropharmacology; 2016 Apr; 103():143-54. PubMed ID: 26702943 [TBL] [Abstract][Full Text] [Related]
15. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation. Jensen JB; du Jardin KG; Song D; Budac D; Smagin G; Sanchez C; Pehrson AL Eur Neuropsychopharmacol; 2014 Jan; 24(1):148-59. PubMed ID: 24284262 [TBL] [Abstract][Full Text] [Related]
16. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. Dale E; Zhang H; Leiser SC; Xiao Y; Lu D; Yang CR; Plath N; Sanchez C J Psychopharmacol; 2014 Oct; 28(10):891-902. PubMed ID: 25122043 [TBL] [Abstract][Full Text] [Related]
17. Histamine may contribute to vortioxetine's procognitive effects; possibly through an orexigenic mechanism. Smagin GN; Song D; Budac DP; Waller JA; Li Y; Pehrson AL; Sánchez C Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jul; 68():25-30. PubMed ID: 26945513 [TBL] [Abstract][Full Text] [Related]
18. Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety. Adell A IDrugs; 2010 Dec; 13(12):900-10. PubMed ID: 21154150 [TBL] [Abstract][Full Text] [Related]
19. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain. El Mansari M; Lecours M; Blier P Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacological properties of vortioxetine and its pre-clinical consequences]. David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]